Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025)
Siga Technologies (SIGA) posted Liabilities and Shareholders Equity of $219.5 million for Q4 2025, down 5.24% on a QoQ basis from $231.6 million in Q3 2025, and down 10.18% year-over-year from $244.3 million in Q4 2024.
Siga Technologies (SIGA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
Siga Technologies' Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $219.5 million for Q4 2025.
- Quarterly Liabilities and Shareholders Equity fell 10.18% year-over-year to $219.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $933.5 million (up 6.62% YoY) and the FY2025 annual result came in at $219.5 million, down 10.18% from the prior year.
- Liabilities and Shareholders Equity was $219.5 million for Q4 2025 at Siga Technologies, down from $231.6 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $254.4 million in Q4 2023 and bottomed at $133.7 million in Q2 2021.
- A 5-year average of $195.9 million and a median of $195.2 million in 2022 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 50.65% — and 2023, when it slipped 22.45%.
- Siga Technologies' Liabilities and Shareholders Equity stood at $214.7 million in 2021, then retreated by 9.17% to $195.0 million in 2022, then jumped by 30.41% to $254.4 million in 2023, then declined by 3.94% to $244.3 million in 2024, then retreated by 10.18% to $219.5 million in 2025.
- Business Quant data shows SIGA's Liabilities and Shareholders Equity at $219.5 million in Q4 2025, $231.6 million in Q3 2025, and $235.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.71 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 69.30 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 219.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 219.47 Mn |
| Sep 30, 2025 | 231.60 Mn |
| Jun 30, 2025 | 235.33 Mn |
| Mar 31, 2025 | 247.07 Mn |
| Dec 31, 2024 | 244.34 Mn |
| Sep 30, 2024 | 195.35 Mn |
| Jun 30, 2024 | 192.66 Mn |
| Mar 31, 2024 | 243.15 Mn |
| Dec 31, 2023 | 254.35 Mn |
| Sep 30, 2023 | 158.38 Mn |
| Jun 30, 2023 | 146.51 Mn |
| Mar 31, 2023 | 183.92 Mn |
| Dec 31, 2022 | 195.04 Mn |
| Sep 30, 2022 | 204.22 Mn |
| Jun 30, 2022 | 159.94 Mn |
| Mar 31, 2022 | 184.55 Mn |
| Dec 31, 2021 | 214.73 Mn |
| Sep 30, 2021 | 135.56 Mn |
| Jun 30, 2021 | 133.69 Mn |
| Mar 31, 2021 | 138.77 Mn |